14 September 2020 – Online Education Company Byju Raising $500m

The Big Ones

Online education has firmly established itself as the key sector in India’s startup space, and Byju’s has effectively confirmed that, raising an amount reported by TechCrunch to be $500m. Byju’s, which is backed by Tencent, Naspers and Times Internet, was valued at $10.8bn post-money in the round, which came in the wake of it adding an extraordinary 20 million users since the start of the Covid-19 lockdown. That means the company has almost trebled its valuation inside two years.

Saudi Aramco has a market cap of some $1.8 trillion but is looking to explore diversification into other areas besides oil and gas (perhaps not surprisingly given the direction of oil prices this year). To that end, it has formed a $1bn fund called Prosperity 7 Ventures that is tasked with investing in innovative technologies like AI, 5G, robotics, blockchain and the internet of things. It will join the company’s Saudi Aramco Energy Ventures unit as well as its Wa’ed Ventures vehicle.

Illumina spinoff Grail has filed for what may be one of this year’s biggest healthtech IPOs. The cancer diagnostics technology developer has set a $100m placeholder target for the offering but has raised $1.9bn in venture funding from investors including Johnson & Johnson, WuXi AppTec, Tencent, Amazon, Varian, Memorial Sloan Kettering Cancer Center, Bristol-Myers Squibb, McKesson, Celgene, Alphabet and Merck & Co. It was valued at a reported $3.2bn back in 2018, prior to its last round.

X-over: Recursion, a University of Utah spinout, is using digital technologies such as automation and machine learning to develop drugs for various diseases and has built up a 30-strong drug pipeline, four of which have reached the clinical trials stage. It has also secured $239m in a series D round led by a $50m investment from Leaps by Bayer. The unit’s parent company, Bayer, has also formed a strategic partnership with Recursion, which was valued at about $1.2bn post-money.

Deals

Industrial technology has not been among the winners during the coronavirus lockdown, but advanced materials producer Zymergen has nevertheless snagged $300m in a series D round led by investment manager Bailie Gifford. The company, which has developed a bio-based polyimide film called Hyaline, has now raised a total of $874m in funding, its earlier backers including SoftBank Vision Fund and Hanwha Asset Management.

A sector that hasn’t done brilliantly – for understandable reasons – is ride hailing, but that impact has been somewhat mitigated by the fact several companies in that space have seen their food delivery businesses pick up. Southeast Asia’s Grab will hypothetically see an uptick in its digital financial services arm, Grab Financial Group, and the subsidiary is reportedly in advanced talks with investors including insurers AIA and Prudential to raise $300m to $500m at a valuation of roughly $2bn. That funding would support an expansion into wealth management and the possible securing of an online banking licence.

Melio, developer of an online payment management platform for businesses, revealed today it has collected a total of $144m in funding since 2018, most recently netting $80m in a series C round last month. It hasn’t provided precise details but did say its backers include American Express Ventures. Amex’s corporate venturing unit has quietly been racking up some big exits over the last two or three years, most notably from Plaid, iZettle and Bill.com, showing that CVC investing can bag some nice returns alongside strategic interests.

AnyVision, an image and facial recognition software provider that counts Qualcomm Ventures and Robert Bosch among its backers, has pulled in $43m in funding from unnamed investors. The deal comes just over a year after its $74m series A round and roughly four months after Microsoft subsidiary M12, a participant in that round, announced it was divesting its stake due to doubts about the ethics of the use of facial recognition technology by governments.

Funds

Thursday/Friday were a heady 24 hours for corporate fund announcements (which included the Saudi Aramco vehicle we talked about earlier). And Toyota Research Institute – Advanced Development has launched an $800m growth-stage fund called Woven Capital that will back Toyota AI Ventures portfolio companies as they grow, in addition to backing external venture funds. Companies backed by the early-stage vehicle that have raised big rounds of late include personal aircraft developer Joby Aviation, driver safety technology provider Nauto and electric bus producer Proterra.

Santander has had a good degree of success since launching its Santander Innoventures unit with $100m in 2014, snagging big exits from iZettle and Kabbage while accessing technology from several portfolio companies. It has now spun off the unit into an autonomously managed fund dubbed Mouro Capital and doubled its capital allocation again from $200m to $400m. It will make initial investments of about $15m at early and growth stage.

Exits

KAR Auction Services has agreed to acquire BacklotCars, the owner of an online dealer-to-dealer automotive marketplace, for $425m, enabling Renren to exit. BacklotCars had raised roughly $50m pre-acquisition. Renren has pulled back from corporate venturing almost completely since 2017, but it’s going to be interesting to see if it can pull some more big exits out of its existing portfolio.

Fabless semiconductor maker 3Peak is set to bag $339m in its IPO, on the red-hot Shanghai Star Exchange. The Huawei-backed company is simply the latest to choose the Star Exchange to go public, the market having benefited from regulations introduced by US exchanges to combat what was perceived as unsatisfactory accounting practices by Chinese companies. It will also jointly host what may be the biggest IPO ever, when Ant Financial floats later this year.

Progress has bought software deployment automation platform Chef in another nine-figure acquisition deal, paying $220m in cash for the company. Chef had received a total of $105m in funding, most recently securing $40m in a 2015 series E round that included Citi Ventures and Hewlett Packard Ventures, which passed its stake in the company on to Hewlett Packard Pathfinder.

Emphysema treatment device developer Pulmonx has filed for an $86.3m offering that would provide exits to Boston Scientific and Posco Bioventures. The former is Pulmonx’s largest investor, the owner of a stake that tops 30%.

Episerver has signed an agreement to purchase Optimizely, a web optimisation software producer that has raised roughly $200m from backers including Accenture Ventures, GV, Citi Ventures and Salesforce Ventures. The size of the deal has not been disclosed but it will consist of a mixture of cash and shares. It comes less than two months after Optimizely revealed it had cut staff numbers by about 15% in the wake of impact from Covid-19.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

Leave a Reply

Your email address will not be published. Required fields are marked *